C07D 277/62
Benzothiazoles
C07D277/62 (Benzothiazoles) appears on 2,813 US grants and 2,443 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,813
- Published applications
- 2,443
- Assignees
- 1,228
- Inventors
- 8,428
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 26 | 0 |
| 1977 | 39 | 0 |
| 1978 | 24 | 0 |
| 1979 | 14 | 0 |
| 1980 | 34 | 0 |
| 1981 | 38 | 0 |
| 1982 | 28 | 0 |
| 1983 | 33 | 0 |
| 1984 | 44 | 0 |
| 1985 | 40 | 0 |
| 1986 | 27 | 0 |
| 1987 | 31 | 0 |
| 1988 | 40 | 0 |
| 1989 | 47 | 0 |
| 1990 | 51 | 0 |
| 1991 | 54 | 0 |
| 1992 | 37 | 0 |
| 1993 | 57 | 0 |
| 1994 | 56 | 0 |
| 1995 | 47 | 0 |
| 1996 | 67 | 0 |
| 1997 | 65 | 0 |
| 1998 | 62 | 0 |
| 1999 | 46 | 0 |
| 2000 | 52 | 0 |
| 2001 | 60 | 9 |
| 2002 | 65 | 78 |
| 2003 | 60 | 102 |
| 2004 | 51 | 143 |
| 2005 | 60 | 126 |
| 2006 | 79 | 126 |
| 2007 | 66 | 105 |
| 2008 | 64 | 114 |
| 2009 | 60 | 128 |
| 2010 | 81 | 133 |
| 2011 | 86 | 97 |
| 2012 | 89 | 88 |
| 2013 | 86 | 87 |
| 2014 | 103 | 124 |
| 2015 | 93 | 107 |
| 2016 | 79 | 105 |
| 2017 | 86 | 88 |
| 2018 | 67 | 103 |
| 2019 | 77 | 80 |
| 2020 | 61 | 97 |
| 2021 | 63 | 69 |
| 2022 | 48 | 73 |
| 2023 | 38 | 85 |
| 2024 | 55 | 85 |
| 2025 | 41 | 57 |
| 2026 | 36 | 34 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compounds and methods of inhibiting bacterial chaperonin systems29 Sep 2026US 12,747,219 B2Arizona Board of Regents on Behalf of the University of Arizona
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Inhibitors of spinster homolog 2 (SPNS2) for use in therapy22 Sep 2026US 12,741,944 B2University of Virginia Patent Foundation
- Benzothiazole and quinoline derivatives and their use22 Sep 2026US 12,741,948 B2Shanghai Yao Yuan Biotechnology Co., Ltd.
- Modulators of programmed death-ligand-122 Sep 2026US 12,741,965 B2Southern Research Institute
- Mitochondrial uncouplers for treatment of metabolic diseases and cancer8 Oct 2026US 2026/0306502 A1Mito Biopharma, LLC
- Biarylamide derivatives and their use as pkmyt1 inhibitors1 Oct 2026US 2026/0297042 A1Cancer Research Technology Limited
- Fabk inhibitor compositions10 Sep 2026US 2026/0265242 A1The Texas A&M University System
- New antibiotic compounds3 Sep 2026US 2026/0258006 A1Centre National De La Recherche Scientifique
- Compounds, compositions and methods of use to treat hypoparathyroidism and osteoporosis3 Sep 2026US 2026/0258007 A1Septerna, Inc.
Most cited
By later US patents
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase226US 5,480,883 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1996
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase209US 5,409,930 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1995
- Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase198US 5,710,158 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1998
- Benzo (b) thiophene carboxylate derivatives and pharmaceutical compositions182US 4,740,519 ACentre International de Recherches Dermatologiques (C.I.R.D.) · 1988
- Expression of a gene for a modified green-fluorescent protein173US 5,741,668 ARutgers, The State University of New Jersey · 1998